首页 > 市场调查报告书 > 医疗设备

导管心血管设备

市场调查报告书

商品编码

1935255

经导管主动脉瓣置换术市场依手术方式、器械、最终用户和地区划分

Transcatheter Aortic Valve Replacement Market, By Procedure Type, By Device Type, By End User, By Geography

出版日期: 2026年01月16日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

经导管主动脉瓣置换术(TAVR) 市场预计在 2026 年达到 81.2 亿美元，预计到 2033 年将达到 137.6 亿美元，2026 年至 2033 年的年复合成长率（CAGR）为 8.2%。

报告内容		报告详情
基准年：	2025	2026年市场规模：	81.2亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	8.20%	2033 年的预测值：	137.6亿美元

随着医疗机构逐渐接受经导管主动脉瓣置换术(TAVR) 作为治疗主动脉瓣狭窄的微创治疗方法方案，TAVR 市场正在迅速扩张。由于 TAVR 具有恢復时间短、併发症率低、生活品质高等优势，医生越来越多地向手术风险较高或中等的患者推荐 TAVR。心血管疾病盛行率的不断上升以及人口老化，正在推动对创新微创心臟治疗方法的需求。

医疗技术的进步，包括新一代瓣膜和改良的输送系统，透过提高手术的安全性和有效性，正在推动市场成长。器械製造商和医疗服务提供者正积极致力于透过持续创新和专业培训，扩大医疗服务的可近性并优化患者治疗效果。人们对早期诊断的意识提升，加上微创手术的广泛应用，正在打造一个充满活力的市场，该市场强调以患者为中心的护理，并在全球范围内拓展主动脉瓣疾病的治疗选择。

市场动态

经导管主动脉瓣置换术（TAVR）市场成长的主要原因是主动脉瓣狭窄盛行率的上升以及人们对微创手术而非传统开胸手术的偏好日益增强。人口老化和全球心血管疾病盛行率的上升，使得人们对有效且创伤较小的治疗方案的需求日益迫切。患者和医疗服务提供者都在积极寻求能够缩短復原时间、降低併发症风险并改善长期疗效的解决方案，这使得TAVR成为高风险和中度风险患者的首选。

技术创新正在积极改变市场格局。製造商正迅速推出新一代经导管瓣膜、先进的输送系统和改进的成像技术，从而提高手术的准确性、安全性和有效性。这些创新使医生能够治疗更广泛的患者群体，包括那些解剖结构复杂的患者，从而扩大了潜在患者群体。医疗机构也正在实施专门的培训计画并升级基础设施，以支援更高的技术应用率和更有效率的手术流程。

儘管TAVR市场成长迅速，但仍面临诸多挑战，例如手术费用高昂、部分地区报销限制以及新兴市场准入有限。患者的个别因素，例如合併症和解剖结构限制，需要周密的计划和个别化的治疗方案。然而，人们对早期诊断的认识不断提高、持续的临床研究以及以患者为中心的创新理念，都在推动市场成长，为TAVR在全球范围内成为安全有效的主动脉瓣疾病治疗方法创造了良好的发展环境。

本次调查的主要特点

本报告对经导管主动脉瓣置换术(TAVR) 市场进行了详细分析，以 2025 年为基准年，给出了预测期 (2026-2033) 内的市场规模（十亿美元）和復合年增长率 (%)。
我们也将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业的竞争策略的重要见解。
该研究根据以下参数对经导管主动脉瓣置换术市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
本报告的研究结果将有助于负责人和经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
这份经导管主动脉瓣置换术市场报告面向该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过经导管主动脉瓣置换术市场分析中使用的各种策略矩阵轻鬆做出决策。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第八章竞争情势

热图分析
市占率分析（3x3矩阵）
公司简介
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- St. Jude Medical
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE &Co. KG.
- Cook Medical

第九章分析师建议

机会
分析师观点
Coherent Opportunity Map

第十章各节

参考
调查方法

简介目录

Product Code: CMI7525

Transcatheter Aortic Valve Replacement Market is estimated to be valued at USD 8.12 Bn in 2026 and is expected to reach USD 13.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.12 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.20%	2033 Value Projection:	USD 13.76 Bn

The transcatheter aortic valve replacement (TAVR) market is expanding rapidly as healthcare providers adopt this minimally invasive alternative to traditional open-heart surgery for treating aortic valve stenosis. Physicians increasingly recommend TAVR for patients at high or intermediate surgical risk because it reduces recovery times, lowers complication rates, and improves quality of life. Rising rates of cardiovascular diseases, along with an aging population, are driving demand for innovative, less invasive cardiac interventions.

Medical technology advancements, including next-generation valves and enhanced delivery systems, are strengthening market growth by improving procedural safety and effectiveness. Device manufacturers and healthcare providers are actively working to increase accessibility and optimize patient outcomes through continuous innovation and professional training. Growing awareness of early diagnosis, combined with wider adoption of minimally invasive procedures, is creating a dynamic market that emphasizes patient-centered care and expands treatment options for aortic valve disease worldwide.

Market Dynamics

The TAVR market grows primarily due to the rising prevalence of aortic valve stenosis and the increasing preference for minimally invasive procedures over traditional open-heart surgery. Aging populations and the global rise in cardiovascular diseases are creating strong demand for effective, less invasive treatment options. Patients and healthcare providers are actively seeking solutions that shorten recovery times, reduce complication risks, and improve long-term outcomes, making TAVR the preferred choice for high- and intermediate-risk patients.

Technological innovations are actively transforming the market. Manufacturers are launching next-generation transcatheter valves, advanced delivery systems, and improved imaging techniques that enhance procedural accuracy, safety, and effectiveness. These innovations allow physicians to treat a broader range of patients, including those with complex anatomies, expanding the potential patient base. Healthcare facilities are also adopting professional training programs and upgrading infrastructure to support higher adoption rates and improve procedural efficiency.

Despite its rapid growth, the TAVR market faces challenges such as high procedural costs, reimbursement limitations in some regions, and restricted access in emerging markets. Patient-specific factors, including comorbidities and anatomical constraints, require careful planning and tailored treatment approaches. Nevertheless, rising awareness of early diagnosis, ongoing clinical research, and a focus on patient-centered innovations continue to propel market growth, creating a dynamic environment that advances TAVR as a safe and effective treatment for aortic valve disease worldwide.

Key Features of the Study

This report provides in-depth analysis of the Transcatheter Aortic Valve Replacement Market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Transcatheter Aortic Valve Replacement Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Edwards Lifesciences Corp., Medtronic Plc., Abbott Laboratories., Boston Scientific Corp., MicroPort Scientific Corp., JenaValve Technology GmbH., Cardiovascular Systems, Inc., Symetis SA., Lepu Medical Technology Co., Ltd., Terumo Corporation., St. Jude Medical (now part of Abbott)., AtriCure, Inc., Vascular Solutions, Inc., Biotronik SE & Co. KG., and Cook Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Transcatheter Aortic Valve Replacement Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Transcatheter Aortic Valve Replacement Market

Market Segmentation

By Procedure Type Insights
- Transfemoral
- Transapical
- Other Approaches
By Device Type Insights
- Balloon-Expandable Valves
- Self-Expanding Valves
By End User Insights
- Hospitals
- Ambulatory Surgical Centers
- Independent Cardiac Catheterization Labs
- Others
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories.
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH.
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- Jude Medical (now part of Abbott).
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Procedure Type
- Market Snippet, By Device Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Transcatheter Aortic Valve Replacement Market, By Procedure Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Transfemoral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Transapical
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Other Approaches
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Transcatheter Aortic Valve Replacement Market, By Device Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Balloon-Expandable Valves
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Self-Expanding Valves
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Transcatheter Aortic Valve Replacement Market, By End User, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Ambulatory Surgical Centers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Independent Cardiac Catheterization Labs
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Transcatheter Aortic Valve Replacement Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Edwards Lifesciences Corp.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Medtronic Plc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Abbott Laboratories
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Boston Scientific Corp.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- MicroPort Scientific Corp.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- JenaValve Technology GmbH
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cardiovascular Systems, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Symetis SA.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Lepu Medical Technology Co., Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Terumo Corporation.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- St. Jude Medical
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- AtriCure, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Vascular Solutions, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Biotronik SE & Co. KG.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cook Medical
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

9. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

经导管主动脉瓣置换术市场依手术方式、器械、最终用户和地区划分

Transcatheter Aortic Valve Replacement Market, By Procedure Type, By Device Type, By End User, By Geography

市场动态